Rep. Pete Sessions

Maddy summaryThis resolution expresses the sense of the House of Representatives that Charleston, South Carolina, should proceed with hosting the 2027 annual meeting of the Organization for Security and Cooperation in Europe Parliamentary Assembly. The bill cites Charleston's existing facilities as suitable for the event and notes that hosting the convention in South Carolina honors the legacy of late Senator Lindsey Olin Graham. It also highlights that the United States has not hosted this specific assembly since 2005. The measure does not change any laws or allocate funding but serves as a formal statement of support for the planned event.

Maddy summaryThe Stop EU Overreach Act directs the United States Trade Representative to initiate a formal investigation within 30 days of enactment to determine if specific European Union environmental and sustainability regulations unfairly burden American commerce. These targeted measures include rules on corporate sustainability due diligence, reporting, deforestation traceability, and carbon border adjustments that apply to US companies based on their operations or supply chains outside the EU. If the investigation concludes that these foreign practices are unreasonable or discriminatory, the USTR is authorized to take retaliatory actions such as imposing duties on imports from EU member states or suspending trade agreement benefits. The bill includes a sunset provision that terminates its requirements for any specific EU measure once the USTR certifies that the European Union has repealed the rule or entered into a binding agreement to exempt US persons from its extraterritorial obligations.

Maddy summaryThis bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.

Maddy summaryThis bill, known as the D.C. Taxing Authority Review Act, modifies the rules for how new taxes and fees proposed by the District of Columbia government are reviewed by Congress. It requires that any D.C. law imposing or increasing a tax or fee must receive explicit approval from a joint resolution passed by both the House of Representatives and the Senate within 60 days, or else the law will not take effect. Additionally, the bill limits the time for debating these specific approval resolutions to one hour, split evenly between supporters and opponents. These changes directly affect the District of Columbia government's ability to enact new financial measures without prior congressional consent.

Maddy summaryThe Main Street Capital Access Act reduces regulatory burdens for smaller banks, particularly those with less than $10 billion in assets. Key provisions include a 3-year phase-in period for new banks to meet capital requirements, lower leverage ratio requirements for rural banks (7.5% for the first 2 years), and a 30-day review process for business plan deviations. The bill also establishes an Office of Independent Examination Review, sets specific timelines for examinations (270 days) and reports (90 days), and creates a "least cost exception" for bank resolutions to prevent excessive concentration of the banking system. These changes aim to promote new bank formation, improve regulatory efficiency, and support community banking while maintaining financial stability.

Maddy summaryThis bill requires pharmacy benefits managers (PBMs) administering prescription drug benefits for federal employee health plans to reimburse pharmacies at specific rates, including the national average drug cost plus a small percentage or $50, whichever is lower. It prohibits PBMs from favoring their own pharmacies, restricting patient choice, or reducing pharmacy payments after claims are processed. The bill establishes $10,000 civil penalties for violations, with debarment from federal health plans after 10 penalties in 10 years. This directly affects PBMs, in-network pharmacies, and federal health benefit plans covering millions of federal employees and their families. The law aims to ensure fair reimbursement practices and maintain pharmacy choice under the Federal Employees Health Benefits Program.

Maddy summaryHR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.

Protecting Privacy in Purchases Act This bill prohibits payment card networks from using merchant codes that distinguish firearms retailers from general-merchandise retailers or sporting-goods retailers. The Department of Justice must enforce this bill and report annually on the resulting investigations and cases.

Maddy summaryThe Sunshine Protection Act of 2025 would make daylight saving time permanent across the United States, ending the current practice of changing clocks twice yearly. It repeals the 1966 law requiring seasonal time changes and adjusts time zone offsets to reflect permanent daylight saving time (e.g., shifting from "4 hours" to "3 hours" in historical references). States that currently opt out of daylight saving time (like Arizona and Hawaii) would retain their existing arrangements, while all other states would adopt permanent daylight saving time unless they choose to stay on standard time. This change would directly affect all U.S. residents by eliminating the need to reset clocks in spring and fall.